Pearls and Pitfalls in the Approach to Patients with Neurotoxic Syndromes

ABSTRACT

Neurotoxins are an important cause of neurologic disorders. A vast number of potentially neurotoxic compounds exist, including prescription drugs, illicit substances, and exposures through the workplace, residence, hobbies, and the environment. Effects of neurotoxins can mimic neurologic illnesses; therefore, it is important to consider neurotoxins in the differential diagnosis of any patient with neurological dysfunction. Paramount to the diagnosis of a possible neurotoxic syndrome is establishing causation. This can be done by a systematic approach utilizing principles in epidemiology and applying them to the individual patient. This approach is discussed in the following article in an attempt to bring structure to solving problems in a complex area of medicine.

KEYWORD

Neurotoxins - neurotoxicology - clinical approach - epidemiology

REFERENCES

• 1 US Congress. Neurotoxicity: Identifying and Controlling Poisons of the Nervous System Washington, DC: Office of Technology Assessment 1990: 3
• 2 Schaumburg H H. Human neurotoxic disease. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology New York: Oxford University Press 2000: 55
• 3 Hill A B. The environment and disease: association or causation?.  Proc R Soc Med . 1965;  58 295-300
• 4 Moeschlin S. Thallium poisoning.  Clin Toxicol . 1980;  17 133-146
• 5 Tromme I, Van Neste D, Dobbelaere F. Skin signs in the diagnosis of thallium poisoning [published erratum appears in Br J Dermatol 1998;139:170].  Br J Dermatol . 1998;  138 321-325
• 6 Bank W J, Pleasure D E, Suzuki K, Nigro M, Katz R. Thallium poisoning.  Arch Neurol . 1972;  26 456-464
• 7 Moore D, House I, Dixon A. Thallium poisoning: diagnosis may be elusive but alopecia is the clue [published erratum appears in BMJ 1993;306:1603].  BMJ . 1993;  306 1527-1529
• 8 Meggs W J, Hoffman R S, Shih R D, Weisman R S, Goldfrank L R. Thallium poisoning from maliciously contaminated food.  J Toxicol Clin Toxicol . 1994;  32 723-770
• 9 Douglas K T, Bunni M A, Baindur S R. Thallium in biochemistry.  Int J Biochem . 1990;  22 429-438
• 10 Gehring P J, Hammond P B. The interrelationship between thallium and potassium in animals.  J Pharmacol Exp Ther . 1967;  155 187-201
• 11 Mulkey J P, Oehme F W. A review of thallium toxicity [published erratum appears in Vet Hum Toxicol 1993;35:511].  Vet Hum Toxicol . 1993;  35 445-453
• 12 Choi I S. Delayed neurologic sequelae in carbon monoxide intoxication.  Arch Neurol . 1983;  40 433-435
• 13 Min S K. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication.  Acta Psychiatr Scand . 1986;  73 80-86
• 14 Klawans H L, Stein R W, Tanner C M, Goetz C G. A pure parkinsonian syndrome following acute carbon monoxide intoxication.  Arch Neurol . 1982;  39 302-304
• 15 Zagami A S, Lethlean A K, Mellick R. Delayed neurological deterioration following carbon monoxide poisoning: MRI findings.  J Neurol . 1993;  240 113-116
• 16 Song S Y, Okeda R, Funata N, Higashino F. An experimental study of the pathogenesis of the selective lesion of the globus pallidus in acute carbon monoxide poisoning in cats.  Acta Neuropathol (Berl) . 1983;  61 232-238
• 17 Okeda R, Funata N, Takano T. The pathogenesis of carbon monoxide encephalopathy in the acute phase: physiological and morphological correlation.  Acta Neuropathol (Berl) . 1981;  54 1-10
• 18 Thom S R. Leukocytes in carbon monoxide: mediated brain oxidative injury.  Toxicol Appl Pharmacol . 1993;  123 234-247
• 19 Raub J A, Mathieu-Nolf M, Hampson N B, Thom S R. Carbon monoxide poisoning: a public health perspective.  Toxicology . 2000;  145 1-14
• 20 Hormes J T, Filley C M, Rosenberg N L. Neurologic sequelae of chronic solvent vapor abuse.  Neurology . 1986;  36 698-702
• 21 Rosenberg N L, Kleinschmidt-DeMasters B K, Davis K A, Dreisbach J N, Hormes J T, Filley C M. Toluene abuse causes diffuse central nervous system white matter changes.  Ann Neurol . 1988;  23 611-614
• 22 Keane J R. Toluene optic neuropathy.  Ann Neurol . 1978;  4 390
• 23 Ehyai A, Freemon F R. Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing.  J Neurol Neurosurg Psychiatry . 1983;  46 349-351
• 24 Streicher H Z, Gabow P A, Moss A H, Kono D, Kaehny W D. Syndromes of toluene sniffing in adults.  Ann Intern Med . 1981;  94 758-762
• 25 Yamanouchi N, Okada S, Kodama K. White matter changes caused by chronic solvent abuse.  AJNR . 1995;  16 1643-1649
• 26 Schaumburg H H. Toluene. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology New York: Oxford University Press 2000: 1186
• 27 Wiedmann K D, Power K G, Wilson J T, Hadley D M. Recovery from chronic solvent abuse.  J Neurol Neurosurg Psychiatry . 1987;  50 1712-1713
• 28 Pryor G T. A toluene-induced motor syndrome in rats resembling that seen in some human solvent abusers.  Neurotoxicol Teratol . 1991;  13 387-400
• 29 Rusyniak D E. Case presentation: 67-year-old man with the diagnosis of Creutzfeldt-Jacob disease: something doesn't smell right.  Internet J Med Toxicol . 2001;  4 6-8
• 30 Burns R, Thomas D W, Barron V J. Reversible encephalopathy possibly associated with bismuth subgallate ingestion.  Br Med J . 1974;  1 220-223
• 31 Lowe D J. Adverse effects of bismuth subgallate: a further report from the Australian Drug Evaluation Committee.  Med J Aust . 1974;  2 664-666
• 32 Supino-Viterbo V, Sicard C, Risvegliato M, Rancurel G, Buge A. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.  J Neurol Neurosurg Psychiatry . 1977;  40 748-752
• 33 Ross J F, Sahenk Z, Hyser C, Mendell J R, Alden C L. Characterization of a murine model for human bismuth encephalopathy.  Neurotoxicology . 1988;  9 581-586
• 34 Martin W R, Sloan J W, Wala E. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.  J Pharmacol Exp Ther . 1990;  255 744-755
• 35 Sloan J W, Martin W R, Wala E P. Dependence-producing properties of alprazolam in the dog.  Pharmacol Biochem Behav . 1990;  35 651-657
• 36 Noyes R, Perry P J, Crowe R R. Seizures following the withdrawal of alprazolam.  J Nerv Ment Dis . 1986;  174 50-52
• 37 Breier A, Charney D S, Nelson J C. Seizures induced by abrupt discontinuation of alprazolam.  Am J Psychiatry . 1984;  141 1606-1607